Head-to-head intra-individual comparison of biodistribution and tumor uptake of (18F)FAPI-74 with (18F)FDG in patients with PDAC: a prospective exploratory study

Background: Radiolabeled fibroblast activation protein (FAP) ligands, a novel class of tracers for PET/CT imaging, have demonstrated very promising results in various oncological, as well as in some benign, diseases with long-term potential to supplant the current pan-cancer agent [18F]FDG in some c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Novruzov, Emil (VerfasserIn) , Giesel, Frederik L. (VerfasserIn) , Mori, Yuriko (VerfasserIn) , Choyke, Peter L. (VerfasserIn) , Dabir, Mardjan (VerfasserIn) , Mamlins, Eduards (VerfasserIn) , Schmitt, Dominik (VerfasserIn) , Antke, Christina (VerfasserIn) , Pinto, Claudio (VerfasserIn) , Soza-Ried, Cristian (VerfasserIn) , Fernandez, Rene (VerfasserIn) , Amaral, Horacio (VerfasserIn) , Kramer, Vasko (VerfasserIn) , Badinez, Leonardo (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2023
In: Cancers
Year: 2023, Jahrgang: 15, Heft: 10, Pages: 1-13
ISSN:2072-6694
DOI:10.3390/cancers15102798
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.3390/cancers15102798
Verlag, kostenfrei, Volltext: https://www.mdpi.com/2072-6694/15/10/2798
Volltext
Verfasserangaben:Emil Novruzov, Frederik L. Giesel, Yuriko Mori, Peter L. Choyke, Mardjan Dabir, Eduards Mamlins, Dominik Schmitt, Christina Antke, Claudio Pinto, Cristian Soza-Ried, Rene Fernandez, Horacio Amaral, Vasko Kramer and Leonardo Badinez

MARC

LEADER 00000caa a2200000 c 4500
001 1853646164
003 DE-627
005 20240307065100.0
007 cr uuu---uuuuu
008 230726s2023 xx |||||o 00| ||eng c
024 7 |a 10.3390/cancers15102798  |2 doi 
035 |a (DE-627)1853646164 
035 |a (DE-599)KXP1853646164 
035 |a (OCoLC)1425214305 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Novruzov, Emil  |d 1988-  |e VerfasserIn  |0 (DE-588)1228349223  |0 (DE-627)1750106647  |4 aut 
245 1 0 |a Head-to-head intra-individual comparison of biodistribution and tumor uptake of (18F)FAPI-74 with (18F)FDG in patients with PDAC  |b a prospective exploratory study  |c Emil Novruzov, Frederik L. Giesel, Yuriko Mori, Peter L. Choyke, Mardjan Dabir, Eduards Mamlins, Dominik Schmitt, Christina Antke, Claudio Pinto, Cristian Soza-Ried, Rene Fernandez, Horacio Amaral, Vasko Kramer and Leonardo Badinez 
246 3 3 |a Head-to-head intra-individual comparison of biodistribution and tumor uptake of (18 F)FAPI-74 with (18 F)FDG in patients with PDAC 
264 1 |c 2023 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Veröffentlicht: 17. Mai 2023 
500 |a Gesehen am 26.07.2023 
500 |a Im Titel ist der Ausdruck "18F" eckig geklammert und die Zahl 18 hochgestellt 
520 |a Background: Radiolabeled fibroblast activation protein (FAP) ligands, a novel class of tracers for PET/CT imaging, have demonstrated very promising results in various oncological, as well as in some benign, diseases with long-term potential to supplant the current pan-cancer agent [18F]FDG in some cancer types. Pancreatic ductal carcinoma (PDAC) belongs to the group of epithelial malignancies with a strong so-called “desmoplastic reaction”, leading to a prominent tumor stroma with cancer-associated fibroblasts that exhibit a marked overexpression of fibroblast activation protein (FAP). The first clinical experiences in PDAC with 68Ga-labeled FAP ligands suggested superior sensitivity to [18F]FDG. However, there is limited data with 18F-labeled FAP derivatives, i.e. [18F]FAPI-74, yet prospective single- and multicenter trials are already ongoing. In this proof-of-concept study, we sought to evaluate the biodistribution, tumor uptake, and lesion detectability in patients with PDAC using [18F]FAPI-74 PET/CT as compared to [18F]FDG PET/CT scans for staging. Methods: This study includes 7 patients (median age 69) who underwent both [18F]FDG PET/CT with contrast-enhancement and [18F]FAPI-74 PET with low-dose CT for primary staging (n = 3) and therapy response control after neoadjuvant (n = 1) or re-staging after palliative therapy (n = 3). The mean interval between PET scans was 11 ± 4 days (range 1-15 days). The [18F]FDG and [18F]FAPI-74 PET/CT scans were acquired at 64 ± 4.1 min (range 61-91 min) and 66.4 ± 6.3 min (range 60-76 min), respectively, after administration of 200 ± 94 MBq (range 79-318 MBq) and 235 ± 88 MBq (range 90-321 MBq), respectively. Quantification of tracer uptake was determined with SUVmax and SUVmean. Furthermore, the tumor-to-background ratio (TBR) was derived by dividing the SUVmax of tumor lesions by the SUVmax of adipose tissue, skeletal muscle, and blood pool. Results: Overall, 32 lesions were detected in 7 patients including primary (n = 7), lung (n = 7), bone (n = 3), lymph node (n = 13), and peritoneal metastases (n = 2). [18F]FAPI-74 detected 22% more lesions compared with [18F]FDG with a better TBR and visual lesion delineation. In one patient the primary lesion could be detected unequivocally with [18F]FAPI-74 but was missed by [18F]FDG imaging. Altogether, most of the lesions demonstrated markedly elevated uptake of [18F]FAPI-74 with a simultaneous lower uptake in the background, providing a very high visual contrast. Conclusion: To the best of our knowledge, this is the first, prospective, intra-individual investigation comparing [18F]FAPI-74 with [18F]FDG imaging in PDAC with encouraging results. These pivotalresults supporta larger, multicentric, prospective study to determine the value of [18F]FAPI-74 in detecting and staging PDAC in comparison with current standard of care imaging. 
650 4 |a FAPI 
650 4 |a FAPI-74 
650 4 |a FDG 
650 4 |a fibroblast activation protein 
650 4 |a pancreas cancer 
650 4 |a PDAC 
650 4 |a PET 
700 1 |a Giesel, Frederik L.  |d 1970-  |e VerfasserIn  |0 (DE-588)129031240  |0 (DE-627)387883878  |0 (DE-576)297457071  |4 aut 
700 1 |a Mori, Yuriko  |e VerfasserIn  |4 aut 
700 1 |a Choyke, Peter L.  |e VerfasserIn  |4 aut 
700 1 |a Dabir, Mardjan  |e VerfasserIn  |4 aut 
700 1 |a Mamlins, Eduards  |e VerfasserIn  |4 aut 
700 1 |a Schmitt, Dominik  |e VerfasserIn  |4 aut 
700 1 |a Antke, Christina  |e VerfasserIn  |4 aut 
700 1 |a Pinto, Claudio  |e VerfasserIn  |4 aut 
700 1 |a Soza-Ried, Cristian  |e VerfasserIn  |4 aut 
700 1 |a Fernandez, Rene  |e VerfasserIn  |4 aut 
700 1 |a Amaral, Horacio  |e VerfasserIn  |4 aut 
700 1 |a Kramer, Vasko  |e VerfasserIn  |4 aut 
700 1 |a Badinez, Leonardo  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Cancers  |d Basel : MDPI, 2009  |g 15(2023), 10, Artikel-ID 2798, Seite 1-13  |h Online-Ressource  |w (DE-627)614095670  |w (DE-600)2527080-1  |w (DE-576)313958548  |x 2072-6694  |7 nnas  |a Head-to-head intra-individual comparison of biodistribution and tumor uptake of (18F)FAPI-74 with (18F)FDG in patients with PDAC a prospective exploratory study 
773 1 8 |g volume:15  |g year:2023  |g number:10  |g elocationid:2798  |g pages:1-13  |g extent:13  |a Head-to-head intra-individual comparison of biodistribution and tumor uptake of (18F)FAPI-74 with (18F)FDG in patients with PDAC a prospective exploratory study 
856 4 0 |u https://doi.org/10.3390/cancers15102798  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.mdpi.com/2072-6694/15/10/2798  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20230726 
993 |a Article 
994 |a 2023 
998 |g 129031240  |a Giesel, Frederik L.  |m 129031240:Giesel, Frederik L.  |d 910000  |d 911400  |d 50000  |e 910000PG129031240  |e 911400PG129031240  |e 50000PG129031240  |k 0/910000/  |k 1/910000/911400/  |k 0/50000/  |p 2 
999 |a KXP-PPN1853646164  |e 4357830710 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"origin":[{"dateIssuedDisp":"2023","dateIssuedKey":"2023"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"physDesc":[{"extent":"13 S."}],"name":{"displayForm":["Emil Novruzov, Frederik L. Giesel, Yuriko Mori, Peter L. Choyke, Mardjan Dabir, Eduards Mamlins, Dominik Schmitt, Christina Antke, Claudio Pinto, Cristian Soza-Ried, Rene Fernandez, Horacio Amaral, Vasko Kramer and Leonardo Badinez"]},"note":["Veröffentlicht: 17. Mai 2023","Gesehen am 26.07.2023","Im Titel ist der Ausdruck \"18F\" eckig geklammert und die Zahl 18 hochgestellt"],"id":{"eki":["1853646164"],"doi":["10.3390/cancers15102798"]},"title":[{"title_sort":"Head-to-head intra-individual comparison of biodistribution and tumor uptake of (18F)FAPI-74 with (18F)FDG in patients with PDAC","title":"Head-to-head intra-individual comparison of biodistribution and tumor uptake of (18F)FAPI-74 with (18F)FDG in patients with PDAC","subtitle":"a prospective exploratory study"}],"relHost":[{"pubHistory":["1.2009 -"],"recId":"614095670","disp":"Head-to-head intra-individual comparison of biodistribution and tumor uptake of (18F)FAPI-74 with (18F)FDG in patients with PDAC a prospective exploratory studyCancers","note":["Gesehen am 27.05.2020"],"title":[{"title_sort":"Cancers","title":"Cancers"}],"id":{"issn":["2072-6694"],"eki":["614095670"],"zdb":["2527080-1"]},"physDesc":[{"extent":"Online-Ressource"}],"name":{"displayForm":["Molecular Diversity Preservation International (MDPI)"]},"part":{"text":"15(2023), 10, Artikel-ID 2798, Seite 1-13","issue":"10","volume":"15","year":"2023","extent":"13","pages":"1-13"},"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"2009","publisherPlace":"Basel","dateIssuedDisp":"2009-","publisher":"MDPI"}],"language":["eng"]}],"person":[{"given":"Emil","role":"aut","display":"Novruzov, Emil","roleDisplay":"VerfasserIn","family":"Novruzov"},{"role":"aut","display":"Giesel, Frederik L.","given":"Frederik L.","roleDisplay":"VerfasserIn","family":"Giesel"},{"family":"Mori","roleDisplay":"VerfasserIn","role":"aut","display":"Mori, Yuriko","given":"Yuriko"},{"given":"Peter L.","display":"Choyke, Peter L.","role":"aut","roleDisplay":"VerfasserIn","family":"Choyke"},{"roleDisplay":"VerfasserIn","family":"Dabir","given":"Mardjan","display":"Dabir, Mardjan","role":"aut"},{"family":"Mamlins","roleDisplay":"VerfasserIn","given":"Eduards","role":"aut","display":"Mamlins, Eduards"},{"family":"Schmitt","roleDisplay":"VerfasserIn","role":"aut","display":"Schmitt, Dominik","given":"Dominik"},{"role":"aut","display":"Antke, Christina","given":"Christina","family":"Antke","roleDisplay":"VerfasserIn"},{"family":"Pinto","roleDisplay":"VerfasserIn","display":"Pinto, Claudio","role":"aut","given":"Claudio"},{"roleDisplay":"VerfasserIn","family":"Soza-Ried","given":"Cristian","display":"Soza-Ried, Cristian","role":"aut"},{"family":"Fernandez","roleDisplay":"VerfasserIn","role":"aut","display":"Fernandez, Rene","given":"Rene"},{"roleDisplay":"VerfasserIn","family":"Amaral","display":"Amaral, Horacio","role":"aut","given":"Horacio"},{"family":"Kramer","roleDisplay":"VerfasserIn","given":"Vasko","role":"aut","display":"Kramer, Vasko"},{"display":"Badinez, Leonardo","role":"aut","given":"Leonardo","roleDisplay":"VerfasserIn","family":"Badinez"}],"recId":"1853646164","titleAlt":[{"title":"Head-to-head intra-individual comparison of biodistribution and tumor uptake of (18 F)FAPI-74 with (18 F)FDG in patients with PDAC"}]} 
SRT |a NOVRUZOVEMHEADTOHEAD2023